Photodynamic therapy and Klatskin tumour: An overview

References

• Konstantinos N, Lazaridis N, Gores GJ. Cholangiocarcinoma. Gastroenterology 2005; 128: 1655–67
   PubMedGoogle Scholar
• Ortner MA, Liebetruth J, Schreiber S, Hanft M, Wruck U, Fusco V, et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 1998; 114: 536–42
   PubMedGoogle Scholar
• Berr F, Wiedemann M, Tannapfel A, Halm U, Kohlhaw KR, Schmidt F, et al. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 2000; 31: 291–8
   PubMedGoogle Scholar
• Wiedmann M, Berr F, Schiefke I, Witzigmann H, Kohlhaw K, Mossner J, et al. Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study. Gastrointest Endosc 2004; 60: 68–75
   PubMed Web of Science ®Google Scholar
• Zoepf T, Jakobs R, Arnold JC, Apel D, Rosenbaum A, Riemann JF. Photodynamic therapy for palliation of nonresectable bile duct cancer – preliminary results with a new diode laser system. Am J Gastroenterol 2001; 96: 2093–7
   PubMedGoogle Scholar
• Dumoulin FL, Gerhardt T, Fuch S, et al. Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc 2003; 57: 860–7
   PubMed Web of Science ®Google Scholar
• Ortner MEJ, Caca K, Berr F, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 2003; 125: 1355–63
   PubMed Web of Science ®Google Scholar
• Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215: 31–8
   PubMed Web of Science ®Google Scholar
• Vauthey JN, Blumgart LH. Recent advances in the management of cholangiocarcinoma. Semin Liver Dis 1994; 14: 109–14
   PubMed Web of Science ®Google Scholar
• Jarnagin WR. Cholangiocarcinoma of the extrahepatic bile ducts. Semin Surg Oncol 2000; 19: 156–76
   PubMedGoogle Scholar
• Bowling TE, Galbraith SM, Hatfield AR, Solano J, Spittle MF. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in nonresectable cholangiocarcinoma. Gut 1996; 39: 852–5
   PubMedGoogle Scholar
• Hejna M, Pruckmayer M, Raderer M. The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer 1998; 34: 977–86
   PubMed Web of Science ®Google Scholar
• Groeningen van CJ. Intravenous and intra-arterial chemotherapeutic possibilities in biliopancreatic cancer. Ann Oncol 1999; 10: 305–7
   Google Scholar
• Sanz-Altamira PM, O'Reilly E, Stuart KE, et al. A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma. Ann Oncol 2001; 12: 501–4
   PubMed Web of Science ®Google Scholar
• McCaughan JS, Mertens BF, Cho C, Barabah RD, Payton HW. Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. A case report. Arch Surg 1991; 126: 111–13
   PubMedGoogle Scholar
• Rumalla A, Baron Th, Wang KK, Gores GJ, Stadheim LM, De Groen PC. Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc 2001; 53: 500–4
   PubMedGoogle Scholar
• Gores GJ. A spotlight on cholangiocarcinoma. Gastroenterology 2003; 125: 1536–8
   PubMedGoogle Scholar
• Sibille A, Lambert R, Sourquet JC, Sabben G, Descos F. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 1995; 108: 337–44
   PubMed Web of Science ®Google Scholar
• Fingar VH, Siegel KA, Wieman TJ, Doak KW. The effects of thromboxane inhibitors on the microvasculature and tumor response in photodynamic therapy. Photochem Photobiol 1993; 58: 393–9
   PubMedGoogle Scholar
• Peterson DA, McKelvey S, Edmondson PR. A hypothesis for the molecular mechanism of tumor killing by porphyrins and light. Med Hypotheses 1981; 7: 201–5
   PubMedGoogle Scholar
• Zhou C. Mechanism of tumor necrosis induced by photodynamic therapy. J Photochem Photobiol B 1989; 3: 299–318
   PubMedGoogle Scholar
• Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol 2000; 1: 212–9
   PubMedGoogle Scholar
• Pahernik SA, Dellian M, Berr F, Tannapfel A, Wittekind C, Goetz AE. Distribution and pharmacokinetics of Photofrin in human bile duct cancer. J Photochem Photobiol B 1998; 47: 58–62
   PubMedGoogle Scholar
• Hayata Y, Kato H, Konaka C, Amemiya R, Ono J, Ogausa J, et al. Photo radiation therapy with hematoporphyrin derivative in early and stage 1 lung cancer. Chest 1994; 86: 169–77
   Google Scholar
• Shim CS, Cheon YK, Cha SW, Bhandari S, Moon JH, Cho YD, et al. Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment. Endoscopy 2005; 37: 425–33
   PubMedGoogle Scholar
• Berr F, Tannapfel A, Lamesch P, Pahernik S, Wiedmann M, Halm U, et al. Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma. J Hepatol 2000; 32: 352–7
   PubMedGoogle Scholar
• Wiedmann M, Caca K, Berr F, Schiefke I, Tannapfel A, Wittekind C, et al. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma. Cancer 2003; 97: 2783–90
   PubMed Web of Science ®Google Scholar
• Oertel M, Schastak SI, Tannapfel A, Hermann R, Sack U, Mössner J, et al. Novel bacteriochlorine for high tissue-penetration: photodynamic properties in human biliary tract cancer cells in vitro and in a mouse tumour model. J Photochem Photobiol B: Biology 2003; 71: 1–10
   PubMed Web of Science ®Google Scholar